Literature DB >> 1896830

Drug treatment of functional dyspepsia.

N J Talley1.   

Abstract

The therapeutic principles that have been applied to patients with peptic ulceration have often also been applied to those with functional dyspepsia, who by definition have no evidence of a structural or biochemical explanation for their symptoms. Treatments offered have included prokinetic drugs, anticholinergics, antacids, H2-receptor antagonists, selective muscarinic M1-receptor blockers, sucralfate, bismuth, antibiotics, and even surgery. The large range of therapies prescribed reflects the uncertainty about pathogenesis and the lack of a satisfactory treatment. Patients with functional dyspepsia should not be lumped into one broad category; treatment needs to be individualized. Certain subgroups of patients with functional dyspepsia may respond to some drug classes, whereas others may not be efficacious, although this remains to be established. The results of therapeutic studies are critically evaluated in this review.

Entities:  

Mesh:

Year:  1991        PMID: 1896830

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  19 in total

Review 1.  Over-the-counter histamine H2-receptor antagonists. How will they affect the treatment of acid-related diseases?

Authors:  S Holt
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

Review 2.  [Functional dyspepsia, diagnosis and therapy].

Authors:  G Holtmann; M von der Ohe
Journal:  Med Klin (Munich)       Date:  1997-01-15

3.  Economic costs of functional dyspepsia.

Authors:  O Nyrén; G Lindberg; E Lindström; R Seensalu
Journal:  Pharmacoeconomics       Date:  1992-05       Impact factor: 4.981

4.  Why do functional gastrointestinal disorders come and go?

Authors:  N J Talley
Journal:  Dig Dis Sci       Date:  1994-04       Impact factor: 3.199

5.  Effect of glyceryl trinitrate on gastric accommodation and symptoms in functional dyspepsia.

Authors:  O H Gilja; T Hausken; C J Bang; A Berstad
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

Review 6.  Management of dyspepsia in general practice. A critical assessment.

Authors:  C Tosetti; V Stanghellini
Journal:  Pharmacoeconomics       Date:  1998       Impact factor: 4.981

7.  Dyspepsia in healthy blood donors. Pattern of symptoms and association with Helicobacter pylori.

Authors:  G Holtmann; H Goebell; M Holtmann; N J Talley
Journal:  Dig Dis Sci       Date:  1994-05       Impact factor: 3.199

8.  Novel associations with dyspepsia: a community-based study of familial aggregation, sleep dysfunction and somatization.

Authors:  N Gathaiya; G R Locke; M Camilleri; C D Schleck; A R Zinsmeister; N J Talley
Journal:  Neurogastroenterol Motil       Date:  2009-06-02       Impact factor: 3.598

Review 9.  Functional dyspepsia. Current treatment recommendations.

Authors:  Gerald Holtmann; Nicholas J Talley
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

Review 10.  Diagnosis and treatment of dyspepsia in the elderly.

Authors:  S E Pound; R C Heading
Journal:  Drugs Aging       Date:  1995-11       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.